Charles Schwab Investment Management Inc Brainstorm Cell Therapeutics Inc. Transaction History

Charles Schwab Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $201,152 - $267,980	-66,828 Reduced 85.55%	11,287 $43,000
Q1 2021 May 17, 2021	BUY	$3.46 - $7.88 $44,547 - $101,455	12,875 Added 19.73%	78,115 $300,000
Q4 2020 Feb 16, 2021	SELL	$3.99 - $17.73 $21,358 - $94,908	-5,353 Reduced 7.58%	65,240 $296,000
Q3 2020 Nov 13, 2020	BUY	$11.19 - $16.92 $20,276 - $30,659	1,812 Added 2.63%	70,593 $1.2 Million
Q2 2020 Aug 14, 2020	BUY	$4.42 - $12.66 $254,123 - $727,874	57,494 Added 509.38%	68,781 $772,000
Q1 2019 May 14, 2019	BUY	$3.37 - $4.34 $38,037 - $48,985	11,287 New	11,287 $49,000

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $62.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.